Neuroimmunology

The Neuroimmunology group is a translational group made up of clinical and basic researchers and researchers collaborating with other centres that complement our experience in neuroimmunology.

The objectives of our research team are:

• To uncover knowledge of the as yet undiscovered etiopathological processes of multiple sclerosis.
• To identify biomarkers of clinical evolution and / or response to treatment that help the physician to be able to make a treatment personalization with the ultimate goal of improving the patient's quality of life.

The investigation into these clinical evolution markers has led us to delve more specifically into oxidative stress, cholesterol esters, and nutrition. Concerning treatment response markers, we are studying changes in dendritic cells of our patients after disease-modifying treatments.

1. The principal investigator is Dr. Luis Brieva Ruiz, head of the neurology section of the Arnau de Vilanova University Hospital of Lleida (HUAV) and pioneer in research into multiple sclerosis (MS) and in creating a reference unit in the care of patients with MS in the province of Lleida since 2000. In this unit, the patient has been treated in a comprehensive manner, receiving clinical, pharmacological, cognitive, emotional and rehabilitative care from the moment of diagnosis.
2. The current professionals who belong to this unit and who make up the Neuroimmunology group in addition to Dr. Brieva are: Dr. Cristina Gonzàlez, Doctor in Neurology at HUAV, Dr. Agustín Sancho, Neurologist at HUAV, Dr. Laura Quibus, Neurologist at HUAV, Silvia Peralta, nurse at the HUAV Day Hospital, Anna Gil, Neuropsychologist and coordinator of the clinical and basic research of the group and the collaborating researchers Dr. Pascual Torres, expert in Biomedicine and laboratory techniques, Dr. Hugo Gonzalo, PhD in metabolic physiopathology and scientific advisor, and Dr. Jose Vicente Hervás, neurologist at the Hospital Broggi de Sant Joan Despí.